Delivery Order SPE2DB22D1202-SPE2DB24FVKY1
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL6CJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $17,653.68 firm fixed-price delivery order is for the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB22D1106 and SPE2DB24FEHZ9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,963.98 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,418.50 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through May 7, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award, valued at $1,088.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D1053|SPE2DX25F6MAB) for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period extending to April 16, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open...
This federal contract award with ID SPE2DB22D2007|SPE2DB24FH8HW was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,671.72, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 5, 2024. Amerisourcebergen Drug Corp is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.36 firm fixed price delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through May 29, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with identification number SPE2DB22D3016|SPE2DB24FAWH3, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $15,802.94 firm fixed-price delivery order is for the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 22, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,072.05, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 11, 2025. This contract award is not associated with a set-aside designation, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,585.67 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,074.34 firm fixed-price delivery order is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime...